Sign in
Taking people in United StatesNo phase

Recording stomach activity in children with digestive symptoms using a body surface device

Studies stomach signals in children with digestive symptoms, compared with healthy children.

Key facts

Who runs it
Children's Hospital of Philadelphia
Where
Cincinnati, Columbus, Kansas City, Philadelphia, and San Diego, United StatesSee the 5 sites
Trial code
Registry title
BSGM to Evaluate Patients With GI Symptoms
Status
Recruiting
People taking part
685 people, planned
Started
1 Oct 2021
Expected to end
30 Jun 2028
Type of study
Observational, 2 groups
Treatments tested
  • Body surface gastric mapping device
Record updated
10 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young people aged 8 to 25 with stomach or gut symptoms, and healthy young people as a comparison group. Stomach activity is recorded with a device placed on the skin.

Age
8 to 25 years
Sex
All sexes
Disease stage
Patients: a confirmed functional gut disorder and/or gut movement (motility) disorder, or having one of the listed gut tests or procedures as part of their care. Healthy group: no active functional gut disorder and no listed procedure planned soon.
Biomarker or test result
Body mass index under 35. Girls aged 11 or older, or who have started having periods, need a negative urine pregnancy test.

Main reasons for not taking part

  • Skin allergies, strong sensitivity to cosmetics or lotions, or open wounds or inflamed skin on the belly
  • Pregnancy
  • A condition where a doctor advises against fasting, or food allergies to the study meal with no substitute possible
  • Not able to lie relaxed and reclined for the visit, or not able to report symptoms in questionnaires
  • Gut movement disorders limited to the food pipe (esophagus)

The registry criteria, word for word

Show all 27 criteriaShow less

Who can take part

  • Males or females age 8 to 25 years
  • Females ≥11 years of age or who have reached menarche must have a negative urine pregnancy test
  • Confirmed diagnosis of a Functional Gastrointestinal and/or Motility Disorder OR undergoing one of the following procedures as part of their clinical care at one of the participating centers:; HRVB; PENFS; ADM; Colonic Manometry; Pyloric Botox; Pyloric Dilation; Gastric Scintigraphy; GES; gammaCore
  • Those with a body mass index of < 35
  • Parental/guardian permission (informed consent) and if appropriate, child assent
  • Males or females age 8 to 25 years
  • Females ≥11 years of age or who have reached menarche must have a negative urine pregnancy test
  • Do not have an active Functional Gastrointestinal disorder (FGID) diagnosis and will not be undergoing any procedures outlined in the recruitment plan in the near future
  • Those with a body mass index of < 35
  • Individuals may include siblings of those with FGIDs
  • Parental/guardian permission (informed consent) and if appropriate, child assent

Who cannot take part

  • History of skin allergies or a history of extreme sensitivity to cosmetics or lotions. Currently open wounds, abrasions, infected or inflamed abdominal skin. (Please note, majority of feeding tubes can be accommodated by the array placement.)
  • Those with any condition, where fasting is not recommended by a physician
  • Any allergies to foods that may be present in the standardized meal that cannot be accommodated with an acceptable substitute meal
  • Those with major developmental delay or cognitive impairment, who are not able to report their symptoms/feelings in the questionnaires
  • Those with GI motility disorders that are limited in the esophagus, and the gastric mapping is restricted to capture relevant data based on the investigator's discretion
  • History of skin allergies or a history of extreme sensitivity to cosmetics or lotions. Currently open wounds, abrasions, infected or inflamed abdominal skin
  • Those with any condition, where fasting is not recommended by a physician
  • Allergies to foods that may be included in the standardized meal that cannot be accommodated with an acceptable substitute meal
  • Those with major developmental delay or cognitive impairment, who are not able to report their symptoms/feelings in the questionnaires
  • Those with GI motility disorders that are limited in the esophagus, and the gastric mapping is restricted to capture relevant data based on the investigator's discretion
  • Pregnant women
  • Those with physical limitations, who are not able to maintain a relaxed reclined position for the study visit duration
  • Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures
  • Pregnant women
  • Those with physical limitations, who are not able to maintain a relaxed reclined position for the study duration
  • Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 8 and 25 years old?

Where in United States

  • Cincinnati Children's Hospital Medical CenterCincinnati, United StatesContact: Khalil El-Chammas, MDTaking people
  • Nationwide Children's HospitalColumbus, United StatesContact: Peter Lu, MD, MSTaking people
  • Children's Mercy HospitalKansas City, United StatesContact: Jose Cocjin, MDTaking people
  • Children's Hospital of PhiladelphiaPhiladelphia, United StatesContact: Hayat Mousa, MDTaking people
  • Alliant International UniversitySan Diego, United StatesContact: Richard Gevirtz, PhDTaking people

About the trial

What the trial wants to find out

The goal of this observational study is to learn about gastric myoelectric activity in children with GI symptoms. The main question it aims to answer is which patterns or signals are associated with GI symptoms as measured by a body surface gastric mapping (BSGM) device. Participants will have their stomach activity recorded for up to 4 hours using the BSGM device and log real-time symptoms. Researchers will compare the recordings of healthy children and children with GI symptoms to define abnormal GI patterns.

The 2 groups in the trial

  • Children with functional GI disorders

    Treatment: Body surface gastric mapping device

  • Healthy controls

    Treatment: Body surface gastric mapping device

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Body Surface Gastric Mapping (BSGM) to Evaluate Patients With Gastrointestinal (GI) Symptoms
Plain-language title
Recording stomach activity in children with digestive symptoms using a body surface deviceGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05880199, who can take part
Record updated
10 February 2026